-5%
Upadacitinib is a JAK inhibitor that works by interfering with the intracellular signaling of cytokines and growth factors, which are involved in immune system processes and the development of rheumatoid arthritis. It prevents the activation of signal transducers and activators of transcription (STATs), which are responsible for gene expression in immune cells.
- Reucent XR is used for treating adults with moderate to severely active rheumatoid arthritis, particularly when there has been an inadequate response or intolerance to methotrexate.